Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million … L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ... The lancet 390 (10113), 2627-2642, 2017 | 7892 | 2017 |
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19· 1 million participants B Zhou, J Bentham, M Di Cesare, H Bixby, G Danaei, MJ Cowan, ... The Lancet 389 (10064), 37-55, 2017 | 2714 | 2017 |
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents E Di Angelantonio, SN Bhupathiraju, D Wormser, P Gao, S Kaptoge, ... The Lancet 388 (10046), 776-786, 2016 | 2675 | 2016 |
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 … B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ... The Lancet 398 (10304), 957-980, 2021 | 1997 | 2021 |
Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes A Zampetaki, S Kiechl, I Drozdov, P Willeit, U Mayr, M Prokopi, A Mayr, ... Circulation research 107 (6), 810-817, 2010 | 1696 | 2010 |
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies AM Wood, S Kaptoge, AS Butterworth, P Willeit, S Warnakula, T Bolton, ... The Lancet 391 (10129), 1513-1523, 2018 | 1172 | 2018 |
Cardioprotection and lifespan extension by the natural polyamine spermidine T Eisenberg, M Abdellatif, S Schroeder, U Primessnig, S Stekovic, T Pendl, ... Nature medicine 22 (12), 1428-1438, 2016 | 951 | 2016 |
Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis PC Haycock, EE Heydon, S Kaptoge, AS Butterworth, A Thompson, ... Bmj 349, 2014 | 890 | 2014 |
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies IL6R Genetics Consortium Emerging Risk Factors Collaboration The Lancet 379 (9822), 1205-1213, 2012 | 890 | 2012 |
Association of cardiometabolic multimorbidity with mortality E Di Angelantonio, S Kaptoge, D Wormser, P Willeit, AS Butterworth, ... Jama 314 (1), 52-60, 2015 | 840 | 2015 |
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions S Kaptoge, L Pennells, D De Bacquer, MT Cooney, M Kavousi, G Stevens, ... The Lancet global health 7 (10), e1332-e1345, 2019 | 826 | 2019 |
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge R Saxena, MF Hivert, C Langenberg, T Tanaka, JS Pankow, ... Nature genetics 42 (2), 142-148, 2010 | 743 | 2010 |
Rising rural body-mass index is the main driver of the global obesity epidemic in adults Nature 569 (7755), 260-264, 2019 | 727 | 2019 |
Lipid-related markers and cardiovascular disease prediction R Used Jama 307 (2499), 506, 2012 | 602 | 2012 |
Telomere length and risk of incident cancer and cancer mortality P Willeit, J Willeit, A Mayr, S Weger, F Oberhollenzer, A Brandstätter, ... Jama 304 (1), 69-75, 2010 | 550 | 2010 |
Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study C Stegemann, R Pechlaner, P Willeit, SR Langley, M Mangino, U Mayr, ... Circulation 129 (18), 1821-1831, 2014 | 539 | 2014 |
Prospective study on circulating MicroRNAs and risk of myocardial infarction A Zampetaki, P Willeit, L Tilling, I Drozdov, M Prokopi, JM Renard, A Mayr, ... Journal of the American College of Cardiology 60 (4), 290-299, 2012 | 528 | 2012 |
Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study PC Haycock, S Burgess, A Nounu, J Zheng, GN Okoli, J Bowden, ... JAMA oncology 3 (5), 636-651, 2017 | 488 | 2017 |
Association of LPA variants with risk of coronary disease and the implications for lipoprotein (a)-lowering therapies: a Mendelian randomization analysis S Burgess, BA Ference, JR Staley, DF Freitag, AM Mason, SF Nielsen, ... JAMA cardiology 3 (7), 619-627, 2018 | 474 | 2018 |
Baseline and on-statin treatment lipoprotein (a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials P Willeit, PM Ridker, PJ Nestel, J Simes, AM Tonkin, TR Pedersen, ... The Lancet 392 (10155), 1311-1320, 2018 | 463 | 2018 |